Search - tctmd.com

Displaying 21 - 40 of 299

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Presenter: Puneet Aggarwal

October 25, 2025

Presentation TCT 2025

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Presenter: Toby Rogers

October 25, 2025

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

Presenter: Philipp von Stein

June 26, 2025

Presentation NY Valves 2025

“Putting a Lid on the Octopus Pot”: A Rare Case of Takotsubo Cardiomyopathy Following Successful Mitral TEER

Presenter: Christopher Cook

June 26, 2025

Presentation NY Valves 2025

MitraClip as a Bridge to Transplant: Reversing Pulmonary Hypertension in End-Stage Idiopathic Cardiomyopathy

Presenter: Eduardo A. Arias

June 26, 2025

Presentation NY Valves 2025

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Presenter: Martin Maron

June 25, 2025

Presentation NY Valves 2025

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

Presenter: Adam B. Greenbaum

June 25, 2025

Presentation NY Valves 2025

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Presenter: Juan B. Grau

June 25, 2025

Presentation NY Valves 2025

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

Presenter: Shepard D. Weiner

June 25, 2025

Presentation NY Valves 2025

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Presenter: Anjali Owens

June 25, 2025

Presentation NY Valves 2025

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Presenter: Abhishek Kumar

June 25, 2025

Presentation NY Valves 2025

Takotsubo Cardiomyopathy With Cardiogenic Shock Misdiagnosed as Old MI, Successfully Treated With TAVR

Presenter: Ryo Bando

June 25, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: David Cohen

February 13, 2025

Presentation THT 2025

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Presenter: Robin Shaw

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Presentation THT Abstracts 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Advertisement

TCT 1318: Safety and short term outcome of coiling of septal perforators in patient with hypertrophic obstructive cardiomyopathy

Septal Ablation Beyond Hypertrophic Cardiomyopathy: Structural Heart Disease Applications

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Transcatheter Aortic Valve Replacement in Systolic Heart Failure and Moderate Aortic Stenosis: Ischemic vs. Non-Ischemic Cardiomyopathy – Insights From the TAVR UNLOAD Trial

“Putting a Lid on the Octopus Pot”: A Rare Case of Takotsubo Cardiomyopathy Following Successful Mitral TEER

MitraClip as a Bridge to Transplant: Reversing Pulmonary Hypertension in End-Stage Idiopathic Cardiomyopathy

Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025

Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME)

Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy

Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies?

A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM

Transcatheter Aortic Valve Replacement in Concomitant Severe Aortic Stenosis and Hypertrophic Obstructive Cardiomyopathy: Effects of Acute Afterload and Preload Changes

Takotsubo Cardiomyopathy With Cardiogenic Shock Misdiagnosed as Old MI, Successfully Treated With TAVR

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies

Gene Therapy to Reverse Acquired Cardiomyopathy and Recover Chronic Heart Failure

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content